hg_127795.1

Basic information about the TSS

---

TSS ID: hg_127795.1 Species: human Chr: chr12		Start: 105330835 End: 105330888 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000546866.1 ENST00000549934.2 AJ311378 HF679086 Distance: 0 GeneID: 387882 HGNC/MGI_ID: HGNC:35164 UniProt_ID: F8VQD4

Gene_name: chromosome 12 open reading frame 75 Gene_symbol: C12orf75 Gene_synonyms: AGD3 OCC-1 OCC1 Gene_source: HGNC:35164

TATA-Box annotation

---

Distance to TSS:	171
Nearest PromoterID:	NM_001145199
Entrez ID:	387882
Nearest Unigene:	Hs.368938
Nearest Refseq:	NM_207376
Nearest Ensembl:	ENSG00000235162
Gene Name:	chromosome 12 open reading frame 75
Gene Alias:	AGD3|OCC-1|OCC1
Gene Description:	chromosome 12 open reading frame 75
Gene Type:	protein-coding
CpG%:	0.145
GC%:	0.79602
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@C12orf75 p2@C12orf75 p3@C12orf75 p4@C12orf75
Sample		p1@C12orf75	p2@C12orf75	p3@C12orf75	p4@C12orf75
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	43.44	2.92	0.78	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	43.30	4.25	1.21	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	36.27	4.63	2.51	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	34.72	5.20	1.25	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	42.07	4.72	1.35	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	36.44	2.71	1.74	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	54.04	6.32	2.40	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	42.63	3.88	1.21	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	36.55	4.49	1.71	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.33	1.16	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.17	1.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	18.29	1.22	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	44.01	5.96	1.29	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.51	5.41	0.60	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	38.20	4.17	0.66	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	37.72	6.54	1.01	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	35.82	5.02	1.09	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	35.85	6.33	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	29.32	2.67	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	34.60	5.57	0.75	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	37.16	7.75	0.67	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	40.22	7.08	1.38	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	35.16	4.78	0.39	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	38.58	4.61	0.97	2.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	38.44	5.68	1.81	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	33.23	3.48	0.63	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.02	7.69	0.00	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	46.91	7.78	1.65	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	38.44	7.59	1.45	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.25	7.06	1.27	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	40.82	9.42	1.26	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	45.13	7.62	1.76	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	44.32	8.65	0.63	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	40.25	12.21	1.48	2.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	45.81	8.79	0.75	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	48.10	8.43	1.53	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	50.28	11.85	1.84	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	38.69	8.66	2.42	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	49.43	14.86	1.89	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	45.85	12.24	2.16	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	53.40	10.35	1.65	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	42.89	12.74	2.34	3.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	62.00	15.40	2.11	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	50.70	12.41	2.62	3.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	57.82	11.44	3.21	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	59.79	14.89	2.56	2.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	65.01	17.03	2.16	2.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	68.55	14.31	2.09	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	61.28	16.52	1.91	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	52.98	16.18	3.03	2.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	43.25	18.04	1.84	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	43.14	14.68	2.22	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	209.88	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	40.81	13.13	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	35.79	9.28	3.31	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	60.40	33.56	8.39	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	50.98	24.34	3.67	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	43.11	11.67	3.57	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	41.11	8.03	3.53	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	39.61	20.75	1.57	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	36.66	7.76	2.12	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	40.94	10.09	1.12	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	79.61	27.07	2.39	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	46.21	11.21	2.04	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	57.51	6.17	3.90	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	61.77	11.71	4.26	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	16.16	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	205.33	47.38	7.90	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	107.74	19.99	8.78	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	97.69	19.83	4.96	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	84.44	22.99	6.10	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	128.50	24.51	6.95	5.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	161.17	23.51	8.04	3.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	173.36	23.85	6.11	4.89
Adipocyte - breast, donor1	11376-118A8	80.14	23.44	3.33	2.53
Adipocyte - breast, donor2	11327-117E4	46.04	14.60	2.09	1.12
Adipocyte - omental, donor1	11473-119C6	39.31	10.81	1.40	0.51
Adipocyte - omental, donor2	11474-119C7	121.09	58.30	8.22	5.98
Adipocyte - omental, donor3	11475-119C8	44.88	19.09	1.67	1.67
Adipocyte - perirenal, donor1	11476-119C9	74.64	22.97	3.19	3.83
Adipocyte - subcutaneous, donor1	11259-116F8	28.59	5.50	1.10	3.30
Adipocyte - subcutaneous, donor2	11336-117F4	42.90	15.81	1.35	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	7.47	3.48	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	8.80	1.17	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	2.83	0.51	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	18.96	3.07	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	8.82	2.94	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	2.82	0.16	0.08	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	1.61	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	3.20	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	2.23	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	4.57	0.83	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	0.25	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	5.89	0.33	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	2.44	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	140.33	7.73	2.65	1.77
Alveolar Epithelial Cells, donor2	11590-120G6	98.61	2.87	3.23	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	52.71	3.59	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	178.65	35.62	7.02	3.78
Amniotic Epithelial Cells, donor2	11613-122A2	78.65	28.45	5.02	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	111.56	20.96	2.88	3.08
Anulus Pulposus Cell, donor1	11248-116E6	20.60	6.75	0.34	0.80
Anulus Pulposus Cell, donor2	11463-119B5	22.04	5.63	1.22	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	131.19	93.90	20.67	22.91
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	154.55	98.55	15.63	22.58
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	177.64	68.49	10.70	12.84
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	154.54	81.31	17.34	20.33
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	132.79	117.61	24.03	31.62
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	157.10	79.21	19.80	13.20
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	142.62	97.14	16.89	17.87
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	175.73	110.68	18.45	26.21
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	150.25	89.68	14.25	19.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	143.50	113.74	17.70	19.21
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	161.10	106.67	18.87	19.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	141.68	94.03	10.03	31.34
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	171.49	105.93	14.99	14.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	170.60	94.17	15.01	24.57
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	222.12	91.38	15.53	13.42
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	173.06	99.66	20.36	17.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	197.63	116.38	20.22	23.24
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	179.88	102.64	19.24	21.92
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	155.10	89.74	9.75	17.56
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	166.85	101.67	18.08	20.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	138.08	85.25	24.01	20.41
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	116.83	109.74	10.62	17.70
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	176.68	102.57	16.98	20.58
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	96.48	79.70	25.17	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	141.26	104.37	20.39	30.10
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	182.90	115.73	18.97	19.73
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	132.04	77.53	15.75	15.75
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	147.64	94.63	19.95	26.79
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	171.02	114.37	16.03	16.25
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	169.82	86.98	18.84	16.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	158.59	111.20	19.24	21.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	177.50	89.07	14.79	19.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	148.40	74.91	18.55	13.56
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	138.63	91.84	19.30	21.06
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	165.59	112.00	19.87	18.67
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	166.32	98.60	15.44	21.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	167.82	100.69	17.80	24.41
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	164.27	99.33	14.77	15.79
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	134.06	75.61	18.43	13.98
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	161.83	100.55	18.12	18.99
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	184.38	109.65	20.32	23.50
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	178.63	96.56	16.53	16.24
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	162.49	98.25	19.84	17.95
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	181.39	105.95	18.14	17.97
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	150.56	85.71	18.53	16.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	166.89	109.85	16.90	16.90
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	173.24	111.92	17.37	19.51
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	150.42	89.65	25.27	14.44
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	140.69	106.43	18.22	26.97
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	162.76	113.56	22.07	21.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	137.72	91.81	20.40	12.75
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	223.47	98.13	13.98	14.75
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	194.67	124.28	18.37	23.33
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	157.59	84.76	18.67	14.99
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	147.71	108.51	15.30	21.03
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	185.15	114.86	21.51	20.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	161.73	94.60	12.21	25.94
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	155.64	99.15	17.72	21.60
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	163.64	106.71	20.65	18.80
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	149.01	94.13	17.45	19.26
Astrocyte - cerebellum, donor1	11500-119F6	67.55	6.75	4.42	1.72
Astrocyte - cerebellum, donor2	11580-120F5	90.37	10.78	8.04	4.79
Astrocyte - cerebellum, donor3	11661-122F5	22.44	2.10	0.42	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	66.93	8.71	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	112.11	15.85	5.18	4.37
Astrocyte - cerebral cortex, donor3	11392-118C6	126.49	14.32	4.33	2.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	120.65	25.35	9.75	9.86
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	123.90	27.69	11.65	7.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	121.08	25.95	9.10	7.74
Basophils, donor1	12241-129G9	10.98	13.60	6.02	2.88
Basophils, donor2	12242-129H1	23.09	87.31	19.12	11.18
Basophils, donor3	12243-129H2	9.41	13.67	2.20	1.91
Bronchial Epithelial Cell, donor1	11511-119G8	18.11	1.72	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	40.69	1.83	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	23.22	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	27.45	1.46	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	25.79	1.38	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	13.32	1.62	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	20.20	1.44	1.03	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	71.73	4.89	2.33	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.62	23.02	5.12	6.40
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	41.37	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	5.07	7.33	1.13	1.69
CD14+ Monocytes, donor2	11305-117B9	6.12	10.02	1.67	1.11
CD14+ Monocytes, donor3	11381-118B4	5.05	11.42	2.85	2.63
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.57	1.13	0.00	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1.90	3.79	0.76	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	0.66	2.30	0.99	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	0.14	0.87	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	2.41	0.30	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	0.71	0.47	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.50	0.50	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.28	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.99	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.00	0.59	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.36	0.18	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.23	0.70	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.58	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	3.33	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.45	0.59	0.00	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.80	0.40	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.21	0.83	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.23	0.46	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1.36	0.45	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.54	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.52	0.52	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.18	0.55	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.70	0.35	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.88	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.35	0.00	0.00	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.74	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.65	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1.23	1.64	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.46	0.93	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.23	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	0.44	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.16	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.17	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	2.30	0.77	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	1.32	1.10	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.84	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	8.13	6.10	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	27.12	6.78	2.71	5.42
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	27.96	11.39	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	33.58	8.00	1.60	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	30.02	11.26	5.36	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	33.69	11.23	2.11	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.08	7.06	2.35	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	46.14	3.95	2.64	7.91
CD19+ B Cells, donor1	11544-120B5	5.75	1.64	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	6.53	7.98	2.90	2.18
CD19+ B Cells, donor3	11705-123B4	16.66	4.04	2.02	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1.21	1.62	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.40	1.20	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	11.04	5.02	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	15.17	23.60	5.62	7.30
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	21.79	34.95	1.50	6.39
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	28.41	41.04	5.86	7.22
CD4+ T Cells, donor1	11225-116C1	14.28	15.35	4.28	3.57
CD4+ T Cells, donor2	11306-117C1	20.21	23.88	1.84	6.74
CD4+ T Cells, donor3	11382-118B5	21.04	20.13	7.32	5.18
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	51.56	41.09	11.23	11.49
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	62.89	33.24	8.76	10.78
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	81.93	34.78	14.95	16.10
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	16.12	8.06	1.90	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.26	4.92	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	23.07	6.59	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	63.73	98.27	17.05	21.97
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	85.41	65.58	15.59	17.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	89.47	68.51	17.57	18.38
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	40.80	56.93	13.45	15.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	38.43	63.24	14.67	11.18
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	30.80	61.60	11.44	14.96
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	36.68	47.65	11.81	9.28
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	62.12	55.47	14.13	12.05
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	65.15	64.82	13.37	18.71
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	10.88	7.07	1.90	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	10.72	9.11	1.07	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	12.55	16.14	5.38	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	77.69	126.46	23.36	22.99
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	86.65	106.79	20.80	22.09
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	111.59	143.11	36.78	33.20
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	23.26	47.02	7.58	10.11
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	34.66	33.79	6.07	10.83
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	25.71	42.27	6.54	10.90
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	42.06	84.62	13.36	12.87
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	56.31	108.94	29.54	24.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	54.44	160.52	30.71	36.29
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	39.32	80.59	14.68	21.60
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	53.99	103.55	19.39	20.12
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	50.82	115.50	13.86	15.40
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	46.20	104.21	15.40	21.85
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	59.55	157.89	19.39	37.39
CD8+ T Cells, donor1	11226-116C2	47.47	68.43	13.42	11.79
CD8+ T Cells, donor2	11307-117C2	39.80	88.98	23.28	22.15
CD8+ T Cells, donor3	11383-118B6	31.81	61.35	13.63	17.17
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	42.67	9.86	4.13	2.06
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	37.86	9.11	4.07	2.40
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	35.02	7.66	4.92	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	28.52	12.31	5.10	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	40.80	6.96	3.84	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	40.02	6.59	3.41	3.87
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	42.59	9.56	6.52	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	42.11	6.58	5.79	3.42
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	34.94	10.55	4.69	2.11
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	43.77	12.08	5.13	3.92
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	45.32	10.46	4.94	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	53.82	11.19	6.66	2.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	31.52	7.88	3.94	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	34.61	9.56	5.92	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	36.55	8.95	2.24	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	38.18	9.00	5.04	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	45.46	9.78	3.16	4.32
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	34.88	8.49	4.24	1.89
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	41.20	6.02	6.65	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	38.75	8.30	4.31	3.08
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	29.81	8.66	2.56	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	40.16	9.18	3.82	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	39.80	8.67	2.36	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	33.28	9.83	2.27	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	57.81	12.04	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.96	14.69	7.69	6.99
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	68.12	15.03	3.01	3.01
Cardiac Myocyte, donor1	11525-119I4	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	11.86	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	10.00	0.95	0.32	0.11
Chondrocyte - de diff, donor1	11261-116G1	221.87	41.60	3.12	4.85
Chondrocyte - de diff, donor2	11338-117F6	70.72	14.93	3.20	0.71
Chondrocyte - de diff, donor3	11410-118E6	57.00	15.82	1.37	2.28
Chondrocyte - re diff, donor2	11339-117F7	68.04	7.16	0.90	1.79
Chondrocyte - re diff, donor3	11411-118E7	47.32	6.47	0.81	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	41.20	6.31	2.30	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	55.58	10.26	7.48	2.78
Ciliary Epithelial Cells, donor3	11399-118D4	49.65	8.05	2.92	2.57
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	54.38	11.37	1.65	2.02
Corneal Epithelial Cells, donor1	11526-119I5	98.59	3.95	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	31.85	4.55	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	69.28	6.14	0.26	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.49	0.50	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1.58	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.97	0.11	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	241.54	384.00	88.83	70.38
Dendritic Cells - plasmacytoid, donor2	11309-117C4	263.76	551.02	112.95	85.53
Dendritic Cells - plasmacytoid, donor3	11385-118B8	229.87	612.67	127.28	98.24
Endothelial Cells - Aortic, donor0	11207-116A1	34.85	2.17	0.33	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	35.79	7.63	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	31.96	1.70	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	29.49	3.15	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	30.54	2.04	0.58	0.87
Endothelial Cells - Artery, donor2	11341-117F9	38.82	4.94	1.65	0.71
Endothelial Cells - Artery, donor3	11413-118E9	21.56	1.58	1.23	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	13.08	2.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.04	6.09	0.61	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.66	2.82	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	26.15	1.78	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	14.06	0.52	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	11.06	0.28	0.71	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	55.22	4.80	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	22.01	5.24	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	39.14	3.48	0.75	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	28.46	1.30	0.43	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	46.90	2.56	0.61	0.85
Endothelial Cells - Vein, donor1	11267-116G7	9.10	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.16	0.00	1.40	1.40
Endothelial Cells - Vein, donor3	11416-118F3	31.09	1.88	0.79	0.31
Eosinophils, donor1	12244-129H3	30.49	45.74	15.25	0.00
Eosinophils, donor2	12245-129H4	1.65	11.55	4.95	3.30
Eosinophils, donor3	12246-129H5	0.00	14.27	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	35.67	2.44	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	122.33	39.41	3.69	3.69
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	99.52	53.98	5.69	8.43
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	76.92	15.71	3.25	3.14
Fibroblast - Aortic Adventitial, donor1	11245-116E3	184.83	62.94	14.19	10.55
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	49.81	23.61	2.73	2.05
Fibroblast - Aortic Adventitial, donor2	11326-117E3	118.02	50.84	8.44	7.49
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.88	6.06	0.53	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	134.54	33.55	3.65	6.31
Fibroblast - Cardiac, donor1	11268-116G8	49.45	7.26	2.72	0.00
Fibroblast - Cardiac, donor2	11345-117G4	40.17	8.34	1.52	3.03
Fibroblast - Cardiac, donor3	11417-118F4	70.50	11.83	2.68	3.63
Fibroblast - Cardiac, donor4	11452-119A3	23.95	2.12	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	46.19	5.58	1.02	1.52
Fibroblast - Cardiac, donor6	11460-119B2	57.45	7.12	2.73	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.74	1.47	0.54	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	6.04	1.29	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	115.72	2.93	4.39	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	237.56	24.45	7.38	4.61
Fibroblast - Conjunctival, donor3	11692-122I9	48.34	12.38	1.87	2.88
Fibroblast - Dermal, donor1	11269-116G9	103.30	33.34	3.29	5.40
Fibroblast - Dermal, donor2	11346-117G5	108.01	12.26	3.77	1.42
Fibroblast - Dermal, donor3	11418-118F5	173.83	87.88	7.62	13.66
Fibroblast - Dermal, donor4	11450-119A1	266.00	34.48	9.72	6.22
Fibroblast - Dermal, donor5	11454-119A5	512.19	98.92	49.89	30.18
Fibroblast - Dermal, donor6	11458-119A9	559.06	120.52	46.29	35.90
Fibroblast - Gingival, donor1	11237-116D4	107.24	22.28	2.92	2.50
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	332.22	170.30	21.75	32.49
Fibroblast - Gingival, donor2	11318-117D4	159.33	24.51	4.74	4.74
Fibroblast - Gingival, donor3	11394-118C8	63.43	7.83	1.55	1.74
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	154.79	38.44	7.27	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	108.19	17.44	3.17	2.82
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	341.26	91.82	18.08	14.34
Fibroblast - Gingival, donor6 (control)	11922-125H5	233.54	78.57	13.52	14.74
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	160.56	64.58	9.53	7.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	335.48	122.41	23.55	16.82
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	167.99	61.36	11.32	9.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	484.95	134.59	37.08	25.01
Fibroblast - Gingival, donor9 (control)	11927-125I1	73.37	25.39	2.64	4.11
Fibroblast - Lung, donor1	11270-116H1	29.91	4.08	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	104.45	22.38	1.49	4.48
Fibroblast - Lung, donor3	11419-118F6	115.86	17.94	5.28	4.85
Fibroblast - Lymphatic, donor1	11506-119G3	150.78	6.66	2.50	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	37.76	8.39	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	64.37	11.20	2.80	2.24
Fibroblast - Mammary, donor1	11540-120B1	204.61	19.08	4.06	3.25
Fibroblast - Mammary, donor2	11620-122A9	191.72	35.95	11.98	11.98
Fibroblast - Mammary, donor3	11701-123A9	113.17	5.96	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	295.03	47.33	10.47	10.67
Fibroblast - Periodontal Ligament, donor2	11319-117D5	362.06	58.40	19.26	16.69
Fibroblast - Periodontal Ligament, donor3	11395-118C9	325.88	51.41	10.71	3.37
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	229.36	72.89	12.21	11.07
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	244.88	87.21	12.96	15.12
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	88.02	14.84	2.20	2.20
Fibroblast - Pulmonary Artery, donor1	11250-116E8	68.86	9.62	2.10	1.88
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	255.21	18.29	4.88	4.88
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	206.47	52.79	11.36	4.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	138.38	41.51	9.09	8.30
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	134.94	56.56	17.66	11.11
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	224.33	97.16	12.26	11.01
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	336.62	133.43	9.85	12.22
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	113.42	51.75	16.55	11.13
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	328.71	130.30	27.20	19.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	65.29	53.65	7.09	7.34
Fibroblast - skin normal, donor1	11553-120C5	363.43	183.77	27.40	24.94
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	161.21	78.60	16.84	10.83
Fibroblast - skin normal, donor2	11561-120D4	469.16	230.56	45.21	38.78
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	117.57	63.47	16.62	14.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	427.15	163.46	29.24	26.01
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	160.35	51.80	7.52	7.18
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	180.64	119.55	32.51	29.89
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	872.84	522.17	131.13	102.26
Fibroblast - skin walker warburg, donor1	11554-120C6	462.86	207.31	42.51	30.87
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	358.96	341.08	50.18	45.01
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1639.82	1240.95	177.28	199.44
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	14.82	0.00	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	123.08	19.07	2.77	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	222.25	56.47	7.81	9.63
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	109.87	13.03	2.56	1.79
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	49.00	0.77	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	41.47	1.91	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	44.50	1.14	0.86	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	40.81	1.10	1.10	3.03
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	28.54	2.51	1.37	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	42.80	1.39	0.20	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	45.20	1.59	0.53	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	30.01	3.26	0.98	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	29.19	1.33	0.44	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	28.83	1.13	0.28	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	27.58	2.22	0.49	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	31.97	1.61	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	88.83	3.84	1.86	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	119.74	7.61	2.35	3.05
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	74.21	5.49	2.03	2.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	56.36	5.70	1.37	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	91.06	8.60	3.49	3.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	108.41	9.84	1.97	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	51.71	5.32	1.18	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	44.35	5.40	2.07	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	51.39	5.59	0.67	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	30.45	3.23	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	44.79	5.26	1.87	1.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	81.31	11.53	2.13	1.86
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.10	2.50	0.62	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.57	3.24	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	32.20	3.76	0.66	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	67.89	13.06	1.75	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	58.40	9.60	1.63	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	35.07	5.57	1.03	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	30.67	4.27	1.73	2.31
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	28.35	3.67	1.00	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.59	3.75	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	29.40	4.67	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	35.17	6.00	0.00	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.96	2.25	1.28	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	23.59	2.08	1.04	1.23
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.19	1.90	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	17.03	2.74	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.18	3.97	0.31	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	26.79	4.17	0.44	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.37	3.09	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.76	6.02	0.74	1.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	21.66	4.55	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	34.27	2.60	1.22	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.58	7.12	1.42	2.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	23.58	2.44	1.08	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.84	4.61	2.03	2.77
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	34.21	9.65	1.75	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	2.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	50.13	10.68	2.64	2.11
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	47.01	11.10	1.21	2.42
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	13.72	1.52	0.00	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	33.24	0.20	1.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	14.79	0.15	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	25.78	0.61	0.00	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	45.06	0.31	0.63	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	44.64	1.70	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	23.06	0.46	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	7.42	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	29.01	1.93	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	49.74	4.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	39.38	2.60	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	33.77	3.71	0.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	6.66	3.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	40.27	2.24	0.56	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	47.39	3.27	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	34.39	2.52	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	42.94	1.91	0.32	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.76	1.36	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	64.73	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	41.23	4.01	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	40.55	2.96	1.48	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	55.91	6.78	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	50.53	7.87	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	30.15	2.53	0.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	15.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	36.13	4.23	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	51.50	7.50	2.28	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	90.96	12.04	1.34	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	48.16	4.24	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	59.57	15.41	3.08	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	77.03	4.97	7.45	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	55.68	3.77	0.94	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	54.31	2.41	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	70.71	6.10	2.54	3.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	53.44	3.99	1.20	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	63.15	7.89	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	63.74	3.54	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	42.01	2.92	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	64.52	5.71	1.32	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	41.54	2.54	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	41.19	5.97	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	40.28	9.70	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	81.03	28.53	5.71	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	97.72	26.20	5.82	4.16
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	120.32	33.73	5.62	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	48.53	20.62	1.90	3.49
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	51.80	28.41	4.18	5.85
Hep-2 cells mock treated, biol_rep1	11898-125E8	16.83	1.97	0.46	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.35	1.86	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	11.15	2.05	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.54	1.53	0.22	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.61	1.07	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	14.85	1.29	0.65	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	16.07	1.99	0.00	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.92	1.72	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.53	2.24	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	20.71	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	169.66	22.94	11.69	5.19
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	57.14	5.64	1.06	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.96	9.44	0.00	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	41.09	4.37	0.52	0.70
Hepatocyte, donor1	11523-119I2	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	3.23	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	0.61	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	39.16	31.98	8.48	7.18
Intestinal epithelial cells (polarized), donor1	11246-116E4	90.36	18.70	1.92	2.45
Iris Pigment Epithelial Cells, donor1	11530-119I9	85.75	22.64	3.84	3.29
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	77.19	11.42	2.28	1.96
Keratinocyte - epidermal, donor2	11349-117G8	27.52	2.34	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	84.43	9.28	1.14	0.85
Keratinocyte - oral, donor1	11251-116E9	50.17	5.68	0.45	0.57
Keratocytes, donor1	11527-119I6	230.02	19.94	7.56	3.78
Keratocytes, donor2	11607-120I5	108.98	21.09	2.34	1.17
Keratocytes, donor3	11688-122I5	31.42	8.69	1.58	1.98
Krukenberg tumor cell line:HSKTC	10687-109F3	213.20	74.73	10.99	6.59
Lens Epithelial Cells, donor1	11529-119I8	92.77	17.26	4.31	1.08
Lens Epithelial Cells, donor2	11609-120I7	34.25	3.69	1.85	1.15
Lens Epithelial Cells, donor3	11690-122I7	57.62	8.78	1.92	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.64	1.07	0.47	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.91	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	15.58	2.20	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	1.08	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.92	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.72	1.19	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.03	1.64	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.33	0.51	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.71	0.70	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	12.66	1.58	0.40	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.54	0.58	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.48	1.11	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.67	1.74	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.07	1.19	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.75	0.96	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.40	2.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.73	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.89	1.10	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	14.81	0.99	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.15	1.46	0.88	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.21	1.00	0.75	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	11.64	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.20	1.62	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.17	1.82	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	0.52	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.54	1.05	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.87	1.20	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	2.06	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.04	1.32	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.59	0.95	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.59	1.32	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.04	0.25	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.85	2.22	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.08	2.22	0.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.66	0.55	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.47	1.61	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.83	1.52	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.34	1.12	0.70	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.44	3.20	0.36	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.00	0.62	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.32	2.86	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.07	1.96	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.24	0.71	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.34	2.10	0.50	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.45	1.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.62	1.19	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	7.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.16	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.65	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.14	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.15	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.05	1.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	9.89	1.74	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	14.86	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.48	0.41	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.22	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	8.12	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.66	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	6.62	1.53	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.94	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.60	1.51	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.82	0.00	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.66	1.25	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.73	1.40	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.19	0.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.76	1.79	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.72	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	12.37	0.71	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	10.33	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	10.75	1.15	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.79	1.13	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.85	3.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	8.59	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.90	0.00	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	2.24	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	11.52	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.06	2.15	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	7.71	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.33	1.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	8.53	2.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.00	0.69	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.29	2.15	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.08	1.35	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.22	1.48	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	10.47	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	7.60	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	7.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	15.33	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.41	0.99	1.48	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	3.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.54	0.50	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	6.31	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1.72	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	9.35	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	7.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.42	1.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	7.00	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.95	1.12	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	10.60	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	7.71	1.16	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.58	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	8.17	1.92	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	7.16	0.80	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	4.25	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.36	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.78	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.28	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	10.77	1.27	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.00	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.20	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	10.61	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.08	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	12.48	0.00	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.92	2.35	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	9.19	0.42	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	10.69	0.93	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	5.35	2.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	16.57	0.53	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.12	0.81	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	6.42	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	10.26	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.85	2.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.46	2.23	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.18	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.93	1.99	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	0.46	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.73	0.55	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	1.57	0.52	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	192.76	70.63	10.09	8.50
Mallassez-derived cells, donor2	11929-125I3	138.33	44.53	5.39	5.23
Mallassez-derived cells, donor3	11930-125I4	136.76	31.69	5.14	3.61
Mammary Epithelial Cell, donor1	11273-116H4	93.17	11.36	1.40	2.59
Mammary Epithelial Cell, donor2	11350-117G9	68.62	11.00	0.29	1.45
Mammary Epithelial Cell, donor3	11422-118F9	64.35	7.23	2.00	1.25
Mast cell - stimulated, donor1	11487-119E2	5.42	2.03	1.36	0.00
Mast cell, donor1	11563-120D6	8.00	2.60	0.76	0.43
Mast cell, donor2	11565-120D8	9.21	3.86	0.59	0.00
Mast cell, donor3	11566-120D9	6.98	2.48	0.23	0.68
Mast cell, donor4	11567-120E1	3.37	1.24	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	4.21	2.00	0.55	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	1.17	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	3.33	0.57	0.11	0.23
Mast cell, expanded, donor8	11941-126A6	2.01	0.33	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	27.46	2.69	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	12.81	1.38	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	15.65	1.81	0.22	0.14
Melanocyte - light, donor1	11274-116H5	19.28	0.47	0.47	0.47
Melanocyte - light, donor2	11351-117H1	8.87	2.05	0.00	0.68
Melanocyte - light, donor3	11423-118G1	14.74	3.47	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	21.35	2.29	0.62	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	21.78	3.50	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	18.21	1.87	0.27	0.00
Meningeal Cells, donor1	11493-119E8	101.85	11.04	6.82	4.22
Meningeal Cells, donor2	11573-120E7	52.38	5.72	3.08	2.64
Meningeal Cells, donor3	11654-122E7	76.29	16.14	5.79	3.02
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	83.84	6.27	2.28	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	82.72	25.46	3.82	3.52
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	38.11	1.31	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	54.94	6.54	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	137.06	29.42	2.87	7.89
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	148.66	56.75	12.28	7.20
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	195.03	98.02	14.58	22.62
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	113.61	6.81	2.86	1.76
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	153.42	13.88	4.38	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	122.56	9.21	2.86	3.07
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	38.09	9.42	0.83	1.80
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.78	0.74	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	13.42	1.97	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.61	0.00	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	70.44	5.12	1.92	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	158.44	38.99	3.90	3.90
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.26	2.50	0.63	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	73.29	8.71	2.18	0.73
Mesothelial Cells, donor1	11247-116E5	90.96	26.25	1.33	2.65
Mesothelial Cells, donor2	12156-128G5	98.09	32.03	5.51	2.50
Mesothelial Cells, donor3	11402-118D7	52.25	10.41	1.01	1.66
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	2.71	0.99	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	2.36	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	0.93	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	1.24	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.81	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	0.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.00	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1.52	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1.49	0.42	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1.19	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.50	0.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1.66	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.61	0.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	0.63	1.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.41	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.64	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.31	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.01	1.52	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.63	0.82	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1.47	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.44	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1.60	0.80	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.98	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.68	1.03	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.84	0.84	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.08	0.42	0.83	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1.81	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	3.34	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	3.98	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.28	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.52	0.52	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1.72	0.43	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.53	0.53	0.00	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	1.50	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1.11	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.72	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	2.31	0.29	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2.79	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.68	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	306.57	131.42	26.93	17.23
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	191.80	96.16	17.25	16.72
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	87.44	10.68	5.34	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	126.05	22.12	13.77	6.26
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	117.89	43.73	5.51	6.85
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	114.90	27.13	4.79	9.58
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	64.59	5.44	8.16	2.72
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	310.56	104.75	16.54	20.21
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	52.32	8.37	1.26	2.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	110.64	25.10	6.51	4.18
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	45.13	4.32	2.16	2.43
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	46.25	9.04	2.94	2.10
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	222.69	44.54	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	50.13	16.38	2.98	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	43.58	18.68	1.89	4.87
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	61.20	16.77	4.08	2.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	47.03	9.14	2.78	1.47
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	45.93	13.30	3.83	4.92
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	57.29	15.91	2.12	4.77
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	82.84	16.81	7.20	4.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	55.79	35.77	4.27	6.24
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	61.15	20.17	6.18	3.09
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	45.68	11.82	3.35	3.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	54.15	10.55	5.63	5.63
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	69.88	21.61	8.27	6.90
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	66.52	12.21	4.50	3.53
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	72.77	65.18	3.79	3.45
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	171.93	80.91	10.11	17.70
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	41.88	11.36	3.79	4.01
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	65.20	20.32	6.35	3.39
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	49.61	28.01	3.56	4.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	75.12	10.73	6.01	3.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	144.44	27.08	36.11
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	42.32	6.00	1.67	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	50.95	14.43	9.92	2.71
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	59.12	18.25	8.33	2.78
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	87.29	22.29	6.50	7.43
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	51.08	14.00	1.51	4.16
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	78.21	19.55	6.84	4.56
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	28.76	1.74	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	71.91	13.12	5.43	4.52
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	73.20	9.70	7.06	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	78.45	13.96	3.99	4.65
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	49.60	8.43	0.50	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	52.45	9.57	4.21	2.68
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	15.73	4.23	1.51	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	47.08	16.80	5.08	2.21
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	54.89	16.26	6.10	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	189.05	97.08	10.22	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	61.58	7.32	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	50.67	11.65	3.15	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.91	2.72	1.21	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	46.68	4.75	1.58	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	63.48	45.35	7.94	7.94
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	217.49	85.98	15.17	5.06
Myoblast, donor1	11241-116D8	101.37	40.62	6.71	6.21
Myoblast, donor2	11322-117D8	63.67	16.49	1.53	3.07
Myoblast, donor3	11398-118D3	135.71	37.00	5.21	4.37
NK T cell leukemia cell line:KHYG-1	10777-110G3	126.82	77.05	15.18	17.07
Natural Killer Cells, donor1	11230-116C6	35.67	76.88	17.22	15.99
Natural Killer Cells, donor2	11311-117C6	37.39	77.20	18.70	16.59
Natural Killer Cells, donor3	11387-118C1	32.95	88.53	15.46	17.85
Neural stem cells, donor1	11275-116H6	56.26	4.36	1.81	2.18
Neural stem cells, donor2	11352-117H2	30.81	1.93	0.00	0.00
Neurons, donor1	11494-119E9	34.14	4.55	3.41	0.00
Neurons, donor2	11574-120E8	22.90	1.32	0.22	0.22
Neurons, donor3	11655-122E8	55.91	7.40	3.29	0.82
Neutrophils, donor1	11233-116C9	1.86	0.00	0.93	0.93
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	6.11	6.11	1.22	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	32.30	11.87	1.07	2.97
Nucleus Pulposus Cell, donor2	11409-118E5	28.65	9.77	1.63	3.58
Nucleus Pulposus Cell, donor3	11462-119B4	20.66	3.21	0.80	0.40
Olfactory epithelial cells, donor1	11933-125I7	161.05	59.88	10.46	11.29
Olfactory epithelial cells, donor2	11934-125I8	268.07	106.24	19.97	23.16
Olfactory epithelial cells, donor3	11935-125I9	143.36	51.76	7.04	10.10
Olfactory epithelial cells, donor4	11936-126A1	97.40	20.16	2.82	2.92
Oligodendrocyte - precursors, donor1	11496-119F2	102.31	12.64	3.61	0.60
Osteoblast - differentiated, donor1	11276-116H7	37.65	8.93	1.06	1.49
Osteoblast - differentiated, donor2	11353-117H3	56.01	10.29	2.29	2.29
Osteoblast - differentiated, donor3	11425-118G3	52.76	10.55	1.24	3.10
Osteoblast, donor1	11277-116H8	40.06	6.25	0.78	1.17
Osteoblast, donor2	11354-117H4	168.56	38.63	6.32	3.51
Osteoblast, donor3	11426-118G4	103.79	18.13	3.73	2.67
Pancreatic stromal cells, donor1	11249-116E7	205.11	89.37	13.73	14.07
Pericytes, donor1	11491-119E6	19.25	1.89	0.33	1.00
Pericytes, donor2	11571-120E5	29.20	4.75	3.62	1.58
Pericytes, donor3	11652-122E5	75.89	17.29	1.63	2.03
Perineurial Cells, donor1	11499-119F5	123.65	25.09	5.54	5.31
Perineurial Cells, donor2	11579-120F4	16.38	1.20	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	14.98	30.60	7.01	3.51
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.61	9.79	2.69	2.94
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	14.62	24.59	5.05	8.28
Placental Epithelial Cells, donor1	11278-116H9	46.16	10.04	0.48	0.96
Placental Epithelial Cells, donor2	11355-117H5	74.30	16.63	3.33	6.65
Placental Epithelial Cells, donor3	11427-118G5	69.89	15.12	2.75	2.94
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	78.80	23.10	3.80	3.80
Preadipocyte - breast, donor1	11467-119B9	58.71	18.20	1.50	1.69
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.84	6.66	0.91	0.26
Preadipocyte - breast, donor2	11328-117E5	79.70	26.12	4.28	2.70
Preadipocyte - omental, donor1	11468-119C1	43.16	12.57	0.53	0.53
Preadipocyte - omental, donor2	11329-117E6	198.16	68.96	7.86	9.17
Preadipocyte - omental, donor3	11403-118D8	135.08	40.83	4.73	7.31
Preadipocyte - perirenal, donor1	11469-119C2	60.04	10.83	0.98	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	84.46	23.65	4.91	3.69
Preadipocyte - subcutaneous, donor2	11356-117H6	239.23	55.43	10.27	7.08
Preadipocyte - subcutaneous, donor3	11428-118G6	148.66	43.76	4.43	5.45
Preadipocyte - visceral, donor1	11280-116I2	178.94	35.68	5.22	4.75
Preadipocyte - visceral, donor2	11357-117H7	160.14	41.88	8.74	5.98
Preadipocyte - visceral, donor3	11429-118G7	195.08	62.69	11.49	11.39
Prostate Epithelial Cells (polarized), donor1	11253-116F2	73.01	24.29	1.96	3.77
Prostate Epithelial Cells, donor2	11331-117E8	77.05	29.11	3.93	4.33
Prostate Epithelial Cells, donor3	11404-118D9	29.27	2.88	0.00	0.49
Prostate Stromal Cells, donor1	11254-116F3	90.44	21.87	2.62	3.99
Prostate Stromal Cells, donor2	11332-117E9	106.14	27.97	4.48	4.30
Prostate Stromal Cells, donor3	11405-118E1	87.17	29.93	3.13	5.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	554.04	68.62	34.67	17.88
Renal Cortical Epithelial Cells, donor2	11596-120H3	472.78	93.85	32.65	17.33
Renal Epithelial Cells, donor1	11517-119H5	430.13	28.91	20.29	11.16
Renal Epithelial Cells, donor2	11597-120H4	368.46	55.48	27.03	12.80
Renal Epithelial Cells, donor3	11678-122H4	426.32	70.82	27.00	14.19
Renal Glomerular Endothelial Cells, donor1	11514-119H2	42.89	4.09	3.40	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	54.18	3.64	2.02	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	104.57	23.76	7.33	3.77
Renal Glomerular Endothelial Cells, donor4	11783-124B1	93.16	3.33	1.33	3.33
Renal Mesangial Cells, donor1	11518-119H6	239.90	31.03	10.12	7.48
Renal Mesangial Cells, donor2	11598-120H5	229.48	32.60	11.91	13.79
Renal Mesangial Cells, donor3	11679-122H5	249.39	32.18	15.54	12.21
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	915.32	129.38	54.49	23.35
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	555.37	107.53	54.40	23.61
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	473.05	83.70	36.26	24.68
Retinal Pigment Epithelial Cells, donor0	11215-116A9	127.57	9.59	2.33	2.07
Retinal Pigment Epithelial Cells, donor1	11528-119I7	58.27	8.81	0.85	2.56
Retinal Pigment Epithelial Cells, donor2	11608-120I6	67.92	5.15	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	26.85	5.02	1.76	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.57	6.41	0.80	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	25.91	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.56	1.10	1.65	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	31.90	4.64	2.32	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	31.34	1.56	0.52	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.44	1.59	1.09	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	31.12	1.45	0.56	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	30.14	1.98	0.12	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	29.14	2.56	1.17	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	32.13	1.16	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	30.39	2.33	0.68	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	24.81	1.66	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	39.06	0.90	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	26.83	1.43	0.72	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.04	1.40	0.21	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	33.63	2.43	1.11	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	22.18	1.34	0.96	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	26.64	0.84	0.84	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	33.45	1.32	0.38	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	26.54	1.33	1.33	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.74	1.75	0.49	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	31.89	1.34	0.76	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	26.16	2.03	0.64	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.30	1.68	1.40	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.93	2.22	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.80	3.10	0.73	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.37	1.84	1.10	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	33.31	2.28	0.54	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	27.83	0.94	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	24.21	1.59	1.39	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	31.34	1.40	1.87	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	35.04	1.45	1.04	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	20.13	1.55	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	30.08	2.30	1.25	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	31.22	1.75	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	27.25	1.19	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	33.35	3.47	1.16	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.96	1.89	0.69	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	27.16	1.23	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	34.80	2.30	0.66	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	27.95	2.56	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	32.40	1.63	0.59	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	30.65	0.80	1.33	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	25.72	1.24	0.83	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	33.81	1.19	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.26	2.42	1.01	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	35.03	2.07	0.75	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	27.25	1.40	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	21.76	0.91	0.30	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	33.41	3.18	1.22	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	46.43	3.93	1.16	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	37.11	3.65	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	38.58	2.71	1.81	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.30	1.13	0.45	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	34.75	3.00	2.70	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	21.49	1.30	1.42	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.56	1.07	1.07	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	45.07	2.40	0.00	0.60
Schwann Cells, donor1	11498-119F4	108.14	8.09	4.33	2.63
Schwann Cells, donor2	11578-120F3	112.28	27.22	3.40	3.40
Schwann Cells, donor3	11659-122F3	91.36	22.35	5.92	5.04
Sebocyte, donor1	11220-116B5	84.36	12.05	2.19	0.55
Sebocyte, donor2	11301-117B5	55.61	5.97	0.46	0.46
Sebocyte, donor3	11378-118B1	78.12	9.28	1.65	3.50
Sertoli Cells, donor1	11255-116F4	114.31	43.07	3.31	3.31
Sertoli Cells, donor2	11333-117F1	59.31	25.42	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	17.95	1.67	0.35	0.35
Skeletal Muscle Cells, donor2	11358-117H8	5.78	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	88.62	6.69	5.85	0.84
Skeletal Muscle Cells, donor4	11451-119A2	65.19	7.07	1.57	2.20
Skeletal Muscle Cells, donor5	11455-119A6	55.74	6.69	1.04	1.49
Skeletal Muscle Cells, donor6	11459-119B1	191.45	26.93	10.00	4.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	55.06	9.32	1.01	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	53.22	9.56	1.71	2.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	121.14	16.27	4.17	2.28
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	23.42	3.62	0.59	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	156.33	16.65	9.41	9.41
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	34.81	6.74	2.34	2.89
Skin - palm, donor1	10286-104F7	18.80	5.37	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	20.04	4.61	0.86	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	16.36	4.09	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	27.00	3.25	0.65	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	25.30	4.31	0.70	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	43.04	5.06	1.27	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	23.68	2.54	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	24.06	2.25	0.30	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	182.37	77.15	11.73	14.19
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	48.47	19.34	2.89	2.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	182.23	44.67	8.82	6.47
Smooth Muscle Cells - Aortic, donor1	11283-116I5	64.97	11.27	2.21	1.77
Smooth Muscle Cells - Aortic, donor2	11360-117I1	78.36	12.99	2.76	3.54
Smooth Muscle Cells - Aortic, donor3	11432-118H1	209.37	42.49	13.13	6.95
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	69.60	9.18	1.86	1.20
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	88.44	24.16	2.88	2.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	195.12	52.24	12.16	11.39
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	42.65	17.26	3.58	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	54.34	6.79	2.36	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	68.05	16.66	1.85	1.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	95.82	9.76	3.25	1.79
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	20.70	4.57	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	60.87	11.37	1.77	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	80.59	13.83	4.77	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	63.71	12.24	1.62	1.77
Smooth Muscle Cells - Colonic, donor2	11320-117D6	58.76	12.70	1.51	3.01
Smooth Muscle Cells - Colonic, donor3	11396-118D1	92.47	18.37	4.20	4.62
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	88.63	15.93	4.02	2.17
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	105.63	39.88	4.31	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	152.12	32.58	9.56	5.98
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	92.18	7.17	1.71	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	35.02	4.95	0.79	1.26
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	288.74	108.39	13.69	15.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	194.79	75.78	15.47	14.34
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	120.76	27.78	10.26	9.06
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	164.25	20.40	6.09	2.65
Smooth Muscle Cells - Prostate, donor1	11257-116F6	261.52	84.82	13.32	17.31
Smooth Muscle Cells - Prostate, donor2	11335-117F3	37.07	8.77	0.75	1.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	114.15	61.39	6.60	6.85
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	196.16	51.41	10.70	8.14
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	59.26	18.75	1.50	3.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	18.09	6.46	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	150.22	13.02	4.19	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	107.54	30.80	4.54	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	77.41	18.18	6.58	3.45
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	66.08	14.75	1.47	2.65
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	167.78	22.49	4.92	3.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	41.58	5.14	0.47	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	107.65	16.98	3.45	2.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	92.29	15.55	3.57	4.59
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	120.34	18.05	6.77	3.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	92.09	13.69	2.52	1.82
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	66.03	11.31	2.09	1.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	65.71	5.71	1.43	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	90.28	17.62	2.94	2.69
Smooth Muscle Cells - Uterine, donor1	11258-116F7	402.13	178.31	32.04	35.13
Smooth Muscle Cells - Uterine, donor3	11466-119B8	268.00	89.82	17.55	16.97
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	42.37	8.36	0.39	1.94
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	87.27	30.41	3.70	2.38
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	45.01	36.45	4.84	7.81
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	109.96	42.76	5.75	4.31
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	116.97	38.61	7.10	4.54
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	302.88	101.22	22.45	15.36
Smooth muscle cells - airway, control, donor1	11966-126D4	83.55	44.19	2.29	5.08
Smooth muscle cells - airway, control, donor2	11967-126D5	75.07	19.57	2.40	3.59
Smooth muscle cells - airway, control, donor3	11968-126D6	104.08	30.51	2.93	3.76
Smooth muscle cells - airway, control, donor4	11969-126D7	98.55	37.59	1.38	5.96
Synoviocyte, donor1	11291-117A4	246.09	82.31	7.24	10.44
Synoviocyte, donor2	11368-117I9	73.08	21.12	1.01	2.18
Synoviocyte, donor3	11440-118H9	79.31	20.33	1.79	1.79
Trabecular Meshwork Cells, donor1	11532-120A2	271.57	32.16	12.15	7.15
Trabecular Meshwork Cells, donor2	11612-122A1	37.66	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	122.03	9.72	3.24	3.94
Tracheal Epithelial Cells, donor1	11292-117A5	42.51	1.65	0.14	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	20.49	3.09	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	20.04	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	14.64	7.14	0.98	0.49
Urethra, donor2	10319-105A4	145.67	50.36	3.60	5.40
Urothelial Cells, donor1	11520-119H8	87.14	9.03	1.59	0.80
Urothelial Cells, donor2	11600-120H7	64.89	5.21	0.00	0.80
Urothelial Cells, donor3	11681-122H7	37.36	2.75	0.23	0.46
Urothelial cells, donor0	11216-116B1	123.04	8.25	1.56	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	59.62	31.14	1.78	9.79
Whole blood (ribopure), donor090309, donation2	12180-129A2	58.61	37.17	5.72	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	35.60	28.75	3.42	6.16
Whole blood (ribopure), donor090325, donation1	12176-128I7	21.35	22.04	3.44	3.10
Whole blood (ribopure), donor090325, donation2	12177-128I8	19.17	19.75	4.65	4.07
Whole blood (ribopure), donor090612, donation1	12182-129A4	40.61	29.15	2.08	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	44.97	22.94	3.67	6.42
Whole blood (ribopure), donor090612, donation3	12184-129A6	36.52	30.13	4.56	3.65
Wilms' tumor cell line:G-401	10809-111A8	46.38	4.19	1.11	0.99
Wilms' tumor cell line:HFWT	10597-108E3	5.28	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	55.58	3.35	1.12	0.84
achilles tendon, donor2	10292-104G4	16.53	6.20	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	77.00	17.59	4.33	4.84
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	99.37	37.61	11.14	11.14
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	105.18	19.11	6.53	7.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	98.78	50.61	9.52	11.16
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	14.62	79.27	5.06	12.65
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	27.49	38.91	8.46	7.61
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	27.49	83.30	13.07	29.94
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1.76	0.88	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	23.28	23.68	4.08	8.17
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.39	0.00	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	11.70	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	5.81	9.53	0.93	3.49
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	37.80	26.93	8.03	7.77
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	38.28	21.04	5.26	9.64
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.01	3.25	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	18.51	10.69	2.47	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.99	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	6.40	0.43	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	4.85	0.91	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	6.02	0.48	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	12.70	1.56	0.45	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.33	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	18.46	9.42	2.64	3.77
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	19.63	26.17	8.29	10.47
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	136.12	12.48	0.00	0.94
adipose tissue, adult, pool1	10010-101C1	8.84	1.55	0.16	0.62
adipose, donor1	10184-103D4	40.46	3.52	0.59	1.17
adipose, donor2	10185-103D5	17.84	0.41	0.41	0.81
adipose, donor3	10186-103D6	23.42	2.72	1.09	0.82
adipose, donor4	10187-103D7	36.40	0.87	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	8.68	0.32	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	162.89	30.55	5.20	8.14
alveolar cell carcinoma cell line:SW 1573	10708-109H6	207.95	61.81	10.36	10.00
amniotic membrane cells, donor1	12235-129G3	155.80	59.82	3.94	6.03
amniotic membrane cells, donor2	12236-129G4	85.20	18.93	1.35	1.69
amniotic membrane cells, donor3	12237-129G5	81.31	33.29	0.29	7.07
amygdala - adult, donor10196	10167-103B5	4.74	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	11.96	4.66	0.81	1.22
amygdala, newborn, donor10223	10360-105E9	7.10	1.94	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	98.30	12.48	2.80	2.04
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	54.71	4.41	1.76	1.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	109.23	7.68	3.01	3.34
aorta, adult, pool1	10052-101G7	160.83	70.41	2.75	5.10
appendix, adult	10189-103D9	56.28	14.36	5.05	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	233.53	62.60	10.32	12.04
artery, adult	10190-103E1	78.80	28.53	6.79	2.72
astrocytoma cell line:TM-31	10425-106D2	86.34	12.17	1.74	2.61
b cell line:RPMI1788	10427-106D4	97.40	18.74	5.06	10.56
basal cell carcinoma cell line:TE 354.T	10702-109G9	524.10	221.13	34.68	25.53
bile duct carcinoma cell line:HuCCT1	10432-106D9	90.00	8.43	1.59	1.59
bile duct carcinoma cell line:TFK-1	10496-107C1	29.46	3.35	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	12.82	2.61	0.54	0.22
blood, adult, pool1	10053-101G8	42.08	48.72	4.43	15.50
bone marrow stromal cell line:StromaNKtert	10686-109F2	172.13	47.10	5.14	5.99
bone marrow, adult	10192-103E3	10.80	5.40	2.02	0.67
brain, adult, donor1	10084-102B3	9.23	5.13	1.03	2.05
brain, adult, pool1	10012-101C3	5.23	1.34	0.33	0.11
brain, fetal, pool1	10085-102B4	34.73	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	55.50	10.24	1.65	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.37	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	30.94	6.31	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	34.94	3.81	0.64	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	0.31	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	14.96	1.84	0.23	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	2.42	0.48	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	26.80	0.94	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	416.85	68.14	11.92	9.19
carcinoid cell line:SK-PN-DW	10719-109I8	31.37	1.27	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	41.52	2.93	2.40	2.66
caudate nucleus - adult, donor10196	10177-103C6	6.91	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	12.38	3.18	0.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	5.35	4.58	1.53	1.53
caudate nucleus, newborn, donor10223	10354-105E3	6.59	1.46	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	14.57	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	6.83	5.55	0.21	0.21
cerebellum, adult, pool1	10083-102B2	12.76	6.55	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	22.42	9.13	0.83	1.66
cerebral meninges, adult	10188-103D8	12.10	5.04	0.76	1.01
cerebrospinal fluid, donor2	10294-104G6	7.31	5.12	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	0.72	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	29.99	4.31	0.33	0.66
cervix, adult, pool1	10013-101C4	74.96	16.59	1.78	1.89
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	52.81	7.94	1.95	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	54.86	10.45	7.84	0.00
choriocarcinoma cell line:BeWo	10423-106C9	56.55	6.34	2.11	1.37
choriocarcinoma cell line:SCH	10785-110H2	165.23	18.24	7.02	4.07
choriocarcinoma cell line:T3M-3	10618-108G6	63.80	10.20	2.13	1.19
chorionic membrane cells, donor1	12238-129G6	197.45	113.40	11.68	17.38
chorionic membrane cells, donor2	12239-129G7	266.28	64.33	12.33	10.64
chorionic membrane cells, donor3	12240-129G8	173.64	113.19	19.78	24.73
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	74.73	254.47	31.30	35.34
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	4.23	1.34	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	2.53	0.21	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.24	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.41	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.88	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	1.56	0.26	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	464.48	43.89	24.92	12.11
clear cell carcinoma cell line:TEN	10636-108I6	354.30	35.40	7.29	4.51
colon carcinoma cell line:CACO-2	10513-107D9	155.22	54.91	7.32	10.62
colon carcinoma cell line:COLO-320	10420-106C6	34.21	2.66	0.38	1.14
colon, adult, donor1	10082-102B1	20.23	4.76	0.00	0.00
colon, adult, pool1	10014-101C5	30.90	5.52	0.47	0.35
colon, fetal, donor1	10070-101I7	24.10	7.42	0.00	3.09
common myeloid progenitor CMP, donor1	12130-128D6	36.67	0.00	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	75.64	6.80	2.55	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	80.60	12.53	5.74	3.02
cord blood derived cell line:COBL-a untreated	10449-106F8	86.44	13.26	6.63	3.24
corpus callosum, adult, pool1	10042-101F6	18.57	4.98	1.22	0.22
cruciate ligament, donor2	10295-104G7	29.99	10.54	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	30.50	10.43	2.41	1.61
diencephalon, adult	10193-103E4	8.64	3.36	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	35.13	2.30	1.15	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	28.72	1.03	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	19.98	1.20	0.96	0.48
ductus deferens, adult	10196-103E7	141.03	53.32	8.97	6.98
duodenum, fetal, donor1, tech_rep1	10071-101I8	34.57	14.40	2.88	5.76
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.99	13.98	0.74	0.74
dura mater, adult, donor1	10041-101F5	6.03	1.82	0.17	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	43.97	1.78	1.11	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	88.41	3.58	1.15	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	30.21	3.08	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	18.77	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	26.55	1.85	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	28.90	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	217.54	16.09	7.04	5.70
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	4.17	1.63	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	84.75	16.89	1.93	1.77
epidermoid carcinoma cell line:A431	10426-106D3	38.79	1.33	0.11	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	66.98	4.95	1.10	0.99
epididymis, adult	10197-103E8	27.00	7.74	0.63	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	19.87	0.35	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	22.54	2.10	0.39	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	20.27	0.98	0.30	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	23.41	3.36	0.67	0.11
esophagus, adult, pool1	10015-101C6	12.32	3.50	0.11	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.13	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	4.83	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	2.10	6.31	0.00	2.10
eye - muscle medial, donor2	10299-104H2	19.35	7.44	2.98	1.49
eye - muscle superior, donor2	10297-104G9	2.29	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	8.74	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	13.22	3.56	0.76	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	57.19	6.03	1.92	1.92
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	94.02	11.40	3.56	3.56
frontal lobe, adult, pool1	10040-101F4	6.38	2.35	0.28	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	49.24	2.10	0.30	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.65	2.19	0.09	0.18
gall bladder, adult	10198-103E9	126.75	34.52	3.14	4.35
gamma delta positive T cells, donor1	11937-126A2	54.76	107.91	26.31	17.72
gamma delta positive T cells, donor2	11938-126A3	64.24	97.48	19.05	20.17
gastric adenocarcinoma cell line:MKN1	10614-108G2	55.76	12.25	2.11	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	37.52	9.67	0.77	0.77
gastric cancer cell line:AZ521	10549-107H9	27.22	0.98	0.49	0.49
gastric cancer cell line:GSS	10560-108A2	46.68	2.75	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	167.23	28.79	10.97	10.51
giant cell carcinoma cell line:LU65	10487-107B1	0.23	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	20.01	1.54	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	13.97	1.50	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	82.54	16.78	3.48	3.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	105.19	17.55	4.07	3.23
glioblastoma cell line:T98G	10485-107A8	39.84	6.51	1.10	2.10
glioma cell line:GI-1	10413-106B8	16.11	3.51	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	10.20	1.46	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	17.09	5.61	0.73	0.49
globus pallidus, adult, donor10258	10367-105F7	9.58	4.11	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	5.86	2.66	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	70.97	26.92	12.24	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	31.36	5.23	15.68
granulosa cell tumor cell line:KGN	10624-108H3	129.92	24.00	7.36	3.84
hIPS +CCl2, biol_rep1	14383-156B9	31.68	1.38	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	18.29	3.66	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	18.03	1.93	0.64	1.29
hIPS, biol_rep1	14380-156B6	17.25	4.31	0.00	0.00
hIPS, biol_rep2	14381-156B7	26.06	1.37	0.00	0.69
hIPS, biol_rep3	14382-156B8	14.35	1.10	3.31	2.21
hairy cell leukemia cell line:Mo	10712-109I1	12.64	0.57	0.86	0.29
heart - mitral valve, adult	10205-103F7	5.38	1.79	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	17.26	10.20	0.00	0.78
heart - tricuspid valve, adult	10207-103F9	2.50	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	0.82	0.20	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	8.74	0.46	0.00	0.00
heart, fetal, pool1	10046-101G1	5.85	0.72	0.21	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	191.59	46.90	7.71	7.10
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	30.94	2.10	0.99	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	33.26	3.64	0.49	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.74	3.03	0.71	0.71
hepatoma cell line:Li-7	10484-107A7	115.11	12.68	2.34	1.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	268.84	57.18	27.34	14.67
hippocampus - adult, donor10196	10169-103B7	4.73	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	12.45	6.12	0.82	0.41
hippocampus, adult, donor10258	10374-105G5	2.49	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	2.11	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	35.40	0.00	0.61	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	26.12	0.59	0.20	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	22.09	0.00	1.52	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	32.70	1.69	0.56	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	41.31	2.84	0.52	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	32.65	1.14	0.38	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	21.90	3.50	2.04	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.31	2.37	0.86	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	34.20	2.09	0.42	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	43.33	5.68	3.08	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	45.48	4.66	1.93	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	45.11	4.04	1.35	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	21.91	0.47	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	26.53	0.98	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	19.20	0.00	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	32.45	0.76	0.38	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	32.71	1.74	0.00	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	24.99	3.00	2.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	20.16	0.75	1.13	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	18.19	1.82	0.91	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.91	0.63	0.00	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	22.54	2.61	0.16	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.39	0.58	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.63	0.90	1.20	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	37.50	1.48	0.92	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	41.94	1.14	1.71	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	46.96	2.86	1.22	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	40.14	2.11	2.11	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.96	1.27	0.32	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	42.67	2.42	0.91	2.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	11.38	1.03	0.00	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	24.57	1.33	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	19.75	2.31	0.00	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	26.84	2.56	1.28	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	27.26	4.54	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	37.97	3.02	1.01	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	34.54	0.00	0.97	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	36.54	1.34	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	32.20	0.49	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	48.59	0.61	0.92	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	74.82	9.76	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	31.11	1.32	0.33	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	25.72	2.74	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	21.35	3.26	0.36	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	16.37	0.36	0.71	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	2.39	0.00	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	37.92	2.71	1.35	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	35.02	2.96	1.62	0.27
immature langerhans cells, donor1	11904-125F5	2.91	0.24	0.48	0.48
immature langerhans cells, donor2	11905-125F6	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	10.60	3.41	0.28	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	5.53	0.98	0.33	0.65
kidney, adult, pool1	10017-101C8	102.73	24.53	3.70	1.60
kidney, fetal, pool1	10045-101F9	45.77	7.00	0.92	1.13
large cell lung carcinoma cell line:IA-LM	10509-107D5	46.58	2.13	1.28	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	27.10	2.49	0.69	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	124.05	15.78	6.24	3.49
left atrium, adult, donor1	10079-102A7	10.90	1.63	0.54	0.00
left ventricle, adult, donor1	10078-102A6	1.52	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	5.20	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	173.16	116.76	14.01	27.30
leiomyoma cell line:15242A	10570-108B3	170.65	128.26	30.98	22.28
leiomyoma cell line:15425	10571-108B4	169.97	80.86	13.11	14.57
leiomyosarcoma cell line:Hs 5.T	10722-110A2	101.59	25.40	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	87.83	14.64	9.41	4.18
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	22.08	1.89	0.71	0.24
liposarcoma cell line:KMLS-1	10782-110G8	92.63	54.99	3.59	8.44
liposarcoma cell line:SW 872	10726-110A6	78.71	16.57	4.39	4.87
liver, adult, pool1	10018-101C9	0.97	0.49	0.00	0.00
liver, fetal, pool1	10086-102B5	2.82	4.70	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	10.94	4.08	0.29	0.29
locus coeruleus, adult, donor10252	10165-103B3	9.41	3.32	0.37	0.74
locus coeruleus, adult, donor10258	10375-105G6	5.08	2.82	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	1.68	1.68	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	67.40	4.84	1.25	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	0.00	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	18.07	3.66	0.24	0.35
lung, fetal, donor1	10068-101I5	28.54	3.42	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	23.37	7.79	2.29	1.37
lymph node, adult, donor1	10077-102A5	10.41	2.84	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	26.96	0.88	0.44	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	198.47	67.31	19.47	10.11
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	39.93	2.55	1.70	0.00
mature adipocyte, donor1	12231-129F8	1.33	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	0.62	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	0.24	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	0.79	0.53	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	25.02	4.77	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	2.26	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	7.54	2.39	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	6.67	3.18	0.32	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	3.84	2.56	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	3.21	2.19	0.00	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	8.49	4.24	0.00	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	5.03	1.08	0.00	1.44
medulla oblongata - adult, donor10196	10174-103C3	9.73	3.24	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	10.68	5.88	1.08	0.46
medulla oblongata, adult, pool1	10038-101F2	11.18	3.51	0.57	0.24
medulla oblongata, newborn, donor10223	10361-105F1	6.25	1.04	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	24.58	2.21	0.22	0.22
medulloblastoma cell line:ONS-76	10759-110E3	27.14	1.59	0.49	0.24
melanoma cell line:COLO 679	10514-107E1	10.35	1.01	0.29	0.14
melanoma cell line:G-361	10465-106H6	10.04	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	43.60	6.15	0.54	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	35.25	2.64	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	57.03	2.85	1.56	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	104.49	32.22	2.92	5.06
mesenchymal precursor cell - adipose, donor2	11748-123G2	75.62	27.09	1.64	4.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	57.97	19.88	3.31	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	95.66	23.04	2.53	3.51
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	64.32	15.60	1.35	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	51.36	22.21	2.78	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	60.07	14.59	1.54	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	30.94	6.44	0.46	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	75.74	12.07	1.72	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	42.27	7.97	0.54	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	211.97	73.12	14.08	12.38
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	35.57	4.61	0.00	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	155.67	46.63	9.69	8.30
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	79.24	10.12	0.35	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	132.30	36.55	4.90	4.29
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	117.54	33.07	6.83	6.47
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	90.00	23.79	1.97	3.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	53.35	13.68	2.28	1.82
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	141.39	50.35	12.17	7.97
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	174.99	50.36	4.93	8.67
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	149.85	39.48	6.30	8.32
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	141.01	23.56	2.21	5.15
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	147.08	39.78	6.58	6.01
mesenchymal stem cell line:Hu5/E18	10568-108B1	186.51	42.94	12.63	8.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	142.94	56.17	10.05	10.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	118.43	52.69	6.39	6.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	152.34	56.54	8.11	8.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	136.17	44.06	7.39	9.55
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	113.91	52.72	8.94	6.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	139.78	53.48	9.14	7.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	133.22	47.16	4.32	6.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	117.70	50.97	6.49	7.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	96.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	149.98	63.16	7.79	12.98
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	127.39	52.21	6.02	8.48
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	130.51	51.92	6.25	9.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	138.60	45.47	11.00	12.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	119.16	46.66	6.04	7.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	109.71	49.94	6.14	5.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	129.73	51.55	6.01	4.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	144.92	35.55	2.73	16.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	134.29	46.48	15.49	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	138.36	60.41	5.52	8.77
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	139.68	42.19	2.91	11.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	152.46	57.57	6.40	9.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	112.85	48.25	4.91	7.36
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	145.38	52.09	7.39	8.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	149.01	39.88	8.39	10.49
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	93.39	42.72	5.96	5.96
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	119.18	28.60	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	131.64	39.14	5.34	5.34
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	132.81	45.08	4.87	17.06
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	54.10	0.00	54.10
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	122.88	54.47	3.80	8.23
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	55.87	16.21	1.72	4.14
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	38.69	23.64	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	11.98	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.89	5.70	0.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	3.97	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.79	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.91	3.12	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	4.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	5.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.08	2.75	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	5.94	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	4.49	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.82	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.64	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	1.82	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.80	4.76	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.22	7.46	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	27.50	4.07	2.04	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	235.98	58.80	15.47	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	282.54	14.17	5.67	2.13
mesothelioma cell line:ACC-MESO-4	10494-107B8	42.63	3.48	0.93	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	8.55	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	71.82	30.31	3.60	2.67
mesothelioma cell line:Mero-25	10850-111F4	63.32	14.98	6.13	2.95
mesothelioma cell line:Mero-41	10851-111F5	161.60	57.70	6.60	7.33
mesothelioma cell line:Mero-48a	10852-111F6	104.52	48.05	5.31	6.42
mesothelioma cell line:Mero-82	10853-111F7	89.09	14.72	3.42	3.68
mesothelioma cell line:Mero-83	10854-111F8	62.64	17.19	3.57	2.72
mesothelioma cell line:Mero-84	10855-111F9	28.31	4.30	0.51	2.27
mesothelioma cell line:Mero-95	10856-111G1	51.14	16.98	1.45	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	216.34	100.38	15.90	11.60
mesothelioma cell line:NCI-H226	10846-111E9	122.17	48.14	8.87	7.42
mesothelioma cell line:NCI-H2452	10848-111F2	45.27	9.57	0.51	1.02
mesothelioma cell line:NCI-H28	10845-111E8	105.60	26.46	3.82	4.07
mesothelioma cell line:No36	10857-111G2	47.95	7.50	2.94	0.98
mesothelioma cell line:ONE58	10858-111G3	78.03	9.75	3.79	2.71
migratory langerhans cells, donor1	11901-125F2	0.58	0.58	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	0.73	0.49	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	1.26	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	138.75	15.02	5.88	3.26
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	27.13	0.64	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	22.34	0.92	0.69	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	63.94	41.29	9.13	12.75
myelodysplastic syndrome cell line:SKM-1	10772-110F7	46.38	5.17	2.40	2.96
myeloma cell line:PCM6	10474-106I6	5.34	0.40	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	113.63	9.64	4.06	5.07
myxofibrosarcoma cell line:NMFH-1	10684-109E9	86.30	6.67	0.59	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.37	0.56	0.00	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.52	0.74	0.07	0.29
nasal epithelial cells, donor2	12227-129F4	36.98	4.42	1.66	1.10
neuroblastoma cell line:CHP-134	10508-107D4	66.26	1.15	2.76	0.92
neuroblastoma cell line:NB-1	10539-107G8	13.66	0.56	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	18.35	0.63	0.63	0.21
neuroblastoma cell line:NH-12	10555-107I6	17.33	0.75	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	11.15	1.19	0.71	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	8.39	0.63	0.16	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	8.86	0.81	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.08	0.00	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	195.37	61.48	12.24	8.25
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	30.61	48.88	6.09	10.15
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	382.64	56.84	8.81	14.41
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	229.55	87.20	15.07	18.27
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	81.19	22.07	2.63	3.42
nucleus accumbens, adult, pool1	10037-101F1	9.19	2.62	0.19	0.28
occipital cortex - adult, donor10196	10172-103C1	16.48	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	8.32	6.44	0.54	0.54
occipital cortex, newborn, donor10223	10355-105E4	4.00	0.73	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	8.66	2.36	0.79	1.31
occipital lobe, fetal, donor1	10073-102A1	39.05	7.29	3.43	2.57
occipital pole, adult, pool1	10036-101E9	4.34	1.50	0.32	0.00
olfactory region, adult	10195-103E6	5.92	3.06	0.57	0.38
optic nerve, donor1	10277-104E7	6.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	40.44	3.42	0.11	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	214.74	20.33	6.32	4.40
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	25.23	3.39	1.19	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	38.00	3.12	0.58	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	117.59	19.70	3.53	2.65
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	142.02	14.02	4.67	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	36.05	8.91	2.33	2.12
ovary, adult, pool1	10020-101D2	21.14	4.45	0.35	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	163.52	23.83	9.35	4.95
pancreas, adult, donor1	10049-101G4	59.26	22.58	0.94	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	22.64	3.35	1.12	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	45.14	5.96	1.36	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	24.51	1.16	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	5.49	2.01	0.27	0.37
parietal cortex, adult, donor10258	10373-105G4	2.20	3.67	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	4.70	2.82	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	7.70	4.28	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	5.64	1.76	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	39.76	5.82	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	2.62	2.24	0.00	0.37
parotid gland, adult	10199-103F1	4.32	0.62	0.00	0.00
penis, adult	10200-103F2	34.38	9.67	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	88.32	4.65	3.16	2.23
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	6.70	0.44	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	2.58	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	6.51	2.37	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	2.51	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	17.20	6.07	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	12.51	2.61	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	15.32	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	29.46	14.41	2.37	2.37
plasma cell leukemia cell line:ARH-77	10840-111E3	45.69	5.83	2.25	2.52
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	38.29	3.89	0.78	0.78
pons, adult, pool1	10033-101E6	11.62	5.94	0.60	0.52
postcentral gyrus, adult, pool1	10032-101E5	4.79	2.27	0.35	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	77.78	3.64	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	286.95	28.86	10.53	6.72
prostate, adult, pool1	10022-101D4	41.45	11.34	0.63	1.36
putamen, adult, donor10196	10176-103C5	11.80	4.49	0.00	1.18
putamen, adult, donor10252	10152-102I8	23.53	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	7.65	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	5.32	1.93	0.00	0.48
putamen, newborn, donor10223	10365-105F5	1.50	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	22.11	1.16	0.29	0.00
rectum, fetal, donor1	10067-101I4	54.25	11.13	2.78	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	251.22	43.67	5.30	6.36
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	165.68	10.36	2.07	1.24
retina, adult, pool1	10030-101E3	5.37	1.69	0.00	0.20
retinoblastoma cell line:Y79	10475-106I7	52.48	2.08	1.30	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	9.28	0.28	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	131.11	25.01	4.55	5.30
salivary acinar cells, donor1	11771-123I7	10.52	2.75	0.65	1.13
salivary acinar cells, donor2	11772-123I8	21.34	8.81	0.83	1.93
salivary acinar cells, donor3	11773-123I9	27.14	3.31	1.32	0.66
salivary gland, adult, pool1	10093-102C3	12.01	2.86	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	60.70	5.48	1.43	1.18
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	74.76	6.70	1.41	0.82
seminal vesicle, adult	10201-103F3	135.97	53.44	3.70	8.99
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.89	5.83	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	199.04	41.77	10.32	10.32
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	262.93	98.35	30.11	17.06
serous cystadenocarcinoma cell line:HTOA	10693-109F9	447.56	78.85	18.54	18.00
signet ring carcinoma cell line:Kato III	10436-106E4	83.12	14.26	2.43	1.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	139.99	20.64	2.45	2.97
skeletal muscle - soleus muscle, donor1	10282-104F3	17.02	7.80	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	27.71	5.88	0.36	0.48
skeletal muscle, fetal, donor1	10066-101I3	7.04	3.02	1.01	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	22.09	8.21	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	527.63	63.70	17.34	14.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	21.43	2.84	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	27.56	1.93	0.19	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	82.74	1.48	1.65	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	53.40	0.64	0.32	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	161.69	11.77	2.62	2.18
small intestine, adult, pool1	10024-101D6	26.64	6.69	0.24	0.96
small intestine, fetal, donor1	10064-101I1	31.94	9.83	0.74	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	114.89	29.75	1.03	3.08
smooth muscle, adult, pool1	10048-101G3	6.20	2.84	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	7.77	0.00	0.00	0.80
spinal cord - adult, donor10196	10181-103D1	9.64	2.52	0.23	0.92
spinal cord, adult, donor10252	10159-103A6	17.35	5.91	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	3.46	4.15	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	34.76	11.59	1.83	1.22
spinal cord, newborn, donor10223	10359-105E8	3.67	4.13	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	202.82	69.00	10.45	8.21
spleen, adult, pool1	10025-101D7	14.10	3.85	1.10	0.88
spleen, fetal, pool1	10044-101F8	8.42	3.97	0.79	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	7.04	0.41	0.10	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	7.60	0.19	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	1.05	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	94.61	7.43	0.78	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	0.90	0.11	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	24.57	0.85	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	119.31	9.31	2.54	1.69
stomach, fetal, donor1	10062-101H8	65.15	7.48	2.14	2.14
submaxillary gland, adult	10202-103F4	11.96	2.85	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	15.37	7.48	1.45	0.42
substantia nigra, adult, donor10258	10371-105G2	5.17	5.69	0.52	1.03
substantia nigra, newborn, donor10223	10358-105E7	5.65	3.53	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	36.91	1.60	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	5.76	1.36	0.08	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	55.56	15.67	0.71	6.41
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	28.57	7.03	0.88	2.64
tenocyte, donor1	11763-123H8	114.51	37.70	4.19	1.05
tenocyte, donor2	11765-123I1	77.83	21.36	1.91	3.05
tenocyte, donor3	11768-123I4	137.52	56.34	3.71	4.45
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	34.16	3.74	2.04	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	50.41	3.55	1.39	1.39
teratocarcinoma cell line:PA-1	10807-111A6	57.50	2.32	1.55	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	42.15	5.33	0.51	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	20.42	0.38	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	17.56	1.20	0.22	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.24	0.65	0.33	0.65
testis, adult, pool1	10026-101D8	105.33	14.50	1.93	2.90
testis, adult, pool2	10096-102C6	134.87	19.40	4.96	2.71
thalamus - adult, donor10196	10168-103B6	8.83	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	12.35	4.53	0.63	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.11	2.64	0.66	0.49
thalamus, newborn, donor10223	10366-105F6	0.58	1.15	0.00	0.00
throat, adult	10209-103G2	17.48	7.74	0.25	0.25
throat, fetal, donor1	10061-101H7	15.84	3.96	0.91	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	31.80	0.60	0.60	0.60
thymus, adult, pool1	10027-101D9	37.68	7.26	2.68	3.18
thymus, fetal, pool1	10043-101F7	30.03	9.35	2.29	2.91
thyroid carcinoma cell line:KHM-5M	10776-110G2	123.39	14.49	4.92	4.79
thyroid carcinoma cell line:TCO-1	10783-110G9	279.52	46.24	16.34	11.87
thyroid, adult, pool1	10028-101E1	4.48	2.15	0.28	0.00
thyroid, fetal, donor1	10060-101H6	5.01	1.58	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	3.08	0.00	0.00
tongue, adult	10203-103F5	13.95	5.35	0.47	0.93
tongue, fetal, donor1	10059-101H5	9.46	1.97	0.00	0.00
tonsil, adult, pool1	10047-101G2	24.84	8.41	2.70	1.70
trachea, adult, pool1	10029-101E2	29.04	4.25	0.57	0.57
trachea, fetal, donor1	10058-101H4	14.23	3.46	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	384.39	178.55	38.62	26.92
transitional-cell carcinoma cell line:5637	10418-106C4	38.40	2.84	0.30	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	66.91	3.92	0.94	1.72
tridermal teratoma cell line:HGRT	10694-109G1	133.18	19.03	15.22	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	241.17	108.18	23.53	24.55
umbilical cord, fetal, donor1	10057-101H3	79.29	18.78	4.17	2.09
uterus, adult, pool1	10100-102D1	43.68	12.11	1.37	0.51
uterus, fetal, donor1	10055-101H1	91.12	28.16	4.10	6.66
vagina, adult	10204-103F6	20.68	2.58	0.00	0.00
vein, adult	10191-103E2	24.11	10.08	1.97	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	87.05	26.97	8.81	9.88